Osmanovic, Alma http://orcid.org/0000-0002-6012-8423
Förster, Alisa http://orcid.org/0000-0002-7842-8483
Widjaja, Maylin
Auber, Bernd
Das, Anibh M.
Christians, Anne
Brand, Frank http://orcid.org/0000-0001-5537-8543
Petri, Susanne http://orcid.org/0000-0002-9783-8584
Weber, Ruthild G. http://orcid.org/0000-0001-6610-1080
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (PRACTIS-Clinician Scientist Program of Hannover Medical School, ME3696/3-1, KO5614/2-1)
Else Kröner-Fresenius-Stiftung (KlinStrucMed Program of Hannover Medical School, KlinStrucMed Program of Hannover Medical School, KlinStrucMed Program of Hannover Medical School)
Medizinischen Hochschule Hannover (Hochschulinterne Leistungsförderung, HiLF)
Petermax Müller-Stiftung
Medizinische Hochschule Hannover (MHH)
Article History
Received: 14 January 2022
Revised: 1 April 2022
Accepted: 4 April 2022
First Online: 3 May 2022
Declarations
:
: AO received honoraria from Biogen; SP received honoraria from Biogen, Cytokinetics, Inc., Desitin Pharma, Novartis, Roche, and Teva. The other authors report no conflict of interest relevant to this study.
: This study was approved by the Ethics Board of Hannover Medical School (ID # 6269) and was, therefore, performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Written informed consent was obtained from all individuals before entering the study.